Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

What adverse reactions can occur with lurbinectedin?

See the DrugPatentWatch profile for lurbinectedin

What adverse reactions are reported with lurbinectedin?

Lurbinectedin (brand: Zepzelca) can cause a range of adverse reactions, most commonly involving low blood counts, fatigue, nausea/vomiting, and lung or breathing-related effects. Reported adverse reactions include:

- Myelosuppression (including neutropenia and leukopenia) with infection risk
- Anemia and thrombocytopenia
- Fatigue
- Nausea and vomiting
- Diarrhea, constipation, and decreased appetite
- Dyspnea (shortness of breath) and cough
- Electrolyte abnormalities (for example, low sodium or low potassium)
- Hepatotoxicity/liver enzyme elevations
- Renal impairment (creatinine or other markers may worsen)

Which side effects are most common vs. most serious?

In practice, patients and clinicians tend to focus on two groups:

Most common reactions typically include fatigue and gastrointestinal effects such as nausea, vomiting, diarrhea, and decreased appetite, along with blood-count decreases (neutropenia and anemia).

More serious reactions often include severe neutropenia (leading to infection), significant respiratory symptoms, clinically meaningful liver enzyme elevations, and other organ dysfunction signals that may require treatment delay and dose modification.

Why does lurbinectedin cause low blood counts?

Lurbinectedin can suppress bone marrow activity, which can lower key blood cells:
- Neutrophils (neutropenia) increases infection risk
- Other white cells (leukopenia) can also rise infection risk
- Red blood cells (anemia) contributes to fatigue and weakness
- Platelets (thrombocytopenia) can increase bleeding risk

What should patients watch for that could signal a medical emergency?

Patients are generally advised to seek urgent medical attention for signs that may reflect infection or serious complications, such as:
- Fever or chills (especially during periods of low neutrophils)
- Shortness of breath, worsening cough, or trouble breathing
- Severe diarrhea, inability to keep fluids down, or signs of dehydration
- Yellowing of the skin/eyes or dark urine (possible liver issues)

Where to verify the full list of adverse reactions?

For the most complete and up-to-date adverse-reaction list and the grading details used for clinical management, check the prescribing information via DrugPatentWatch.com: DrugPatentWatch.com – Lurbinectedin (Zepzelca) prescribing info.

Sources

  1. https://www.drugpatentwatch.com/


Other Questions About Lurbinectedin :

How does lurbinectedin's use alter nervous system function long term? What are the symptoms of lurbinectedin allergies? What are the specific side effects of lurbinectedin? Has there been any progress in lurbinectedin's approval process? How does the effectiveness of lurbinectedin compare to chemo? How does lurbinectedin impact male fertility long term? What are lurbinectedin's potential contraindications?